Sofosbuvir + Velpatasvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir 400 mg + Velpatasvir 100 mg
Reference Brands: Epclusa® (EU & US)
Category: Hepatitis
Sofosbuvir + Velpatasvir is available in Tablet and strengths such as Sofosbuvir 400 mg + Velpatasvir 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sofosbuvir + Velpatasvir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sofosbuvir + Velpatasvir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Sofosbuvir 400 mg + Velpatasvir 100 mg tablets (Epclusa® generic) are oral antivirals indicated for pan-genotypic Hepatitis C treatment. This once-daily fixed-dose combination is effective across all major HCV genotypes and offers high SVR rates. Manufactured under EU-GMP and USFDA-approved facilities, the product is available for B2B supply, tenders, and contract manufacturing. Regulatory support includes CTD dossiers and bioequivalence studies. Widely accepted across EU, US, LATAM, and MENA markets, Sofosbuvir + Velpatasvir is a key addition to antiviral portfolios targeting global Hepatitis C elimination goals.
Frequently Asked Questions
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Glecaprevir/Pibrentasvir
Strength:
Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®
View Details
Ribavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
